Corrigendum to “Mitigation of NADH:ubiquinone oxidoreductase deficiency by chronic Trolox treatment” (BBA - Bioenergetics (2008) 1777(7–8) (853–859), (S0005272808000686) (10.1016/j.bbabio.2008.03.028));Mitigation of NADH: Ubiquinone oxidoreductase deficiency by chronic Trolox treatment

Biochimica et Biophysica Acta - Bioenergetics

Volumn 1777, Issue 7-8, 2008, Pages 853-859

  Koopman, Werner J H ^a   Verkaart, Sjoerd ^a,b   van Emst de Vries, Sjenet E ^a   Grefte, Sander ^a   Smeitink, Jan A M ^b   Nijtmans, Leo G J ^b   Willems, Peter H G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Complex I deficiency; Mitochondria; Reactive oxygen species; Vitamin E

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TROLOX C;

ARTICLE; CLINICAL ARTICLE; COMPLEX I DEFICIENCY; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; LONG TERM EXPOSURE; NDUFS1 GENE; NDUFS2 GENE; NDUFS7 GENE; NDUFS8 GENE; NDUFV1 GENE; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN FIBROBLAST;

EID: 46349094407     PISSN: 00052728     EISSN: 18792650     Source Type: Journal    
DOI: 10.1016/j.bbabio.2018.06.003     Document Type: Erratum

References (48)

1. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 79 (1999) 1127-1155
2. Smeitink J.A.M., van den Heuvel L.W., and DiMauro S. The genetics and pathology of oxidative phosphorylation. Nat. Rev., Genet. 2 (2001) 342-352
3. Meeusen S., McCaffery J.M., and Nunnari J. Mitochondrial fusion intermediates revealed in vitro. Science 305 (2004) 1747-1752
4. Shoubridge E.A. Nuclear genetic defects of oxidative phosphorylation. Hum. Mol. Genet. 10 (2001) 2277-2284
5. Zeviani M., Spinazzola A., and Carelli V. Nuclear genes in mitochondrial disorders. Curr. Op. Genet. Dev. 13 (2003) 262-270
6. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
7. Carrol J., Fearnley I.M., Skehel J.M., Shannon R.J., Hirst J., and Walker J.E. Bovine complex I is a component of 45 different subunits. J. Biol. Chem. 281 (2006) 32724-32727
8. Budde S.M., van den Heuvel L.P., Smeets R.J., Skladal D., Mayr J.A., Boelen C., Petruzzella V., Papa S., and Smeitink J.A.M. Clinical heterogeneity in patients with mutations in the NDUFS4 gene of mitochondrial complex I. J. Inherit. Metab. Dis. 26 (2003) 813-815
9. Benit P., Slama A., Cartault F., Giurgea I., Chretien D., Lebon S., Marsac C., Munnich A., Rotig A., and Rustin P. Mutant NDUFS3 subunit of mitochondrial complex I causes Leigh syndrome. J. Med. Genet. 41 (2004) 14-17
10. Janssen R.J.R.J., van den Heuvel L.P., and Smeitink J.A.M. Genetic defects in the oxidative phosphorylation (OXPHOS) system. Expert Rev. Mol. Diagn. 4 (2004) 89-102
11. Kirby D.M., Salemi R., Sugiana C., Ohtake A., Parry L., Bell K.M., Kirk E.P., Boneh A., Taylor R.W., Dahl H.H., Ryan M.T., and Thorburn D.R. NDUFS6 mutations are a novel cause of lethal neonatal mitochondrial complex I deficiency. J. Clin. Invest. 114 (2004) 837-845
12. Ogilvie I., Kennaway N.G., and Shoubridge E.A. A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J. Clin. Invest. 115 (2005) 2784-2792
13. Ugalde C., Janssen R.J., van den Heuvel L.W., Smeitink J.A.M., and Nijtmans L.G. Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency. Hum. Mol. Genet. 13 (2004) 659-667
14. Iuso A., Scacco S., Piccoli C., Bellomo F., Petruzzella V., Trentadue R., Minuto M., Ripoli M., Capitanio N., Zeviani M., and Papa S. Dysfunctions of cellular oxidative metabolism in patients with mutations in the NDUFS1 and NDUFS4 genes of complex I. J. Biol. Chem. 281 (2006) 10374-10380
15. Kerscher S., Grgic L., Garofano A., and Brandt U. Application of the yeast Yarrowia lipolytica as a model to analyse human pathogenic mutations in mitochondrial complex I (NADH:ubiquinone oxidoreductase). Biochim. Biophys. Acta 1659 (2004) 197-205
16. Koopman W.J.H., Visch H.J., Verkaart S., van den Heuvel L.W., Smeitink J.A.M., and Willems P.H.G.M. Mitochondrial network complexity and pathological decrease in complex I activity are tightly correlated in isolated human complex I deficiency. Am. J. Physiol., Cell Physiol. 289 (2005) C881-C890
17. 2+ handling in human complex I deficiency. J. Biol. Chem. 279 (2004) 40328-40336
18. Visch H.J., Koopman W.J.H., Leusink A., van Emst-de Vries S.E., van den Heuvel L.W., Willems P.H.G.M., and Smeitink J.A.M. Decreased agonist-stimulated mitochondrial ATP production caused by a pathological reduction in endoplasmic reticulum calcium content in human complex I deficiency. Biochim. Biophys. Acta 1762 (2005) 115-123
19. Luo X., Pitkänen S., Kassovska-Bratinova S., Robinson B.H., and Lehotay D.C. Excessive formation of hydroxyl radicals and aldehydic lipid peroxidation products in cultured skin fibroblasts from patients with complex I deficiency. J. Clin. Invest. 99 (1997) 2877-2882
20. Pitkänen S., and Robinson B.H. Mitochondrial complex I deficiency leads to increased production of superoxide radicals and induction of superoxide dismutase. J. Clin. Invest. 98 (1996) 345-351
21. Tompkins A.J., Burwell L.S., Digerness S.B., Zaragosa C., Holman W.L., and Brookes P.S. Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim. Biophys. Acta 1762 (2006) 223-231
22. Koopman W.J.H., Verkaart S., van Emst-de Vries S.E., Grefte S., Smeitink J.A.M., and Willems P.H.G.M. Simultaneous quantification of oxidative stress and cell spreading using 5-(and -6)-chloromethyl-2′,7′-dichlorofluorescein. Cytometry A 69 (2006) 1184-1192
23. Verkaart S., Koopman W.J.H., van Emst-de Vries S.E., Nijtmans L.G., van den Heuvel L.W., Smeitink J.A.M., and Willems P.H.G.M. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim. Biophys. Acta 1772 (2007) 373-381
24. Verkaart S., Koopman W.J.H., Cheek J., van Emst-de Vries S.E., van den Heuvel L.W., Smeitink J.A.M., and Willems P.H.G.M. Mitochondrial and cytosolic thiol redox state are not detectably altered in isolated human NADH:ubiquinone oxidoreductase deficiency. Biochim. Biophys. Acta 1772 (2007) 1041-1051
25. Choksi K.B., Boylston W.H., Rabek J.P., Widger W.R., and Papaconstantinou J. Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochim. Biophys. Acta 1688 (2004) 95-101
26. Chen Y.R., Chen C.W., Zhang L., Green-church K.B., and Zweier J.L. Superoxide generation from mitochondrial NADH dehydrogenase induces self inactivation with specific protein radical formation. J. Biol. Chem. 280 (2005) 37339-37348
27. Basoah A., Matthews P.M., and Morten K.J. Rapid rates of newly synthesized mitochondrial protein degradation are significantly effected by the generation of mitochondrial free radicals. FEBS Lett. 579 (2005) 6511-6517
28. Hinerfeld D., Traini M.D., Weinberger R.P., Cochran B., Doctrow S.R., Harry J., and Melov S. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J. Neurochem. 88 (2004) 657-667
29. Mattiazzi M., Vijayvergiya C., Gajewski C.D., DeVivo D.C., Lenaz G., Wiedmann M., and Manfredi G. The mtDNA T8993G (NARP) mutation results in an impairment of oxidative phosphorylation that can be improved by antioxidants. Hum. Mol. Genet. 13 (2004) 869-879
30. Navarro A., Gomez C., Sanchez-Pino M.J., Gonzalez H., Bandez M.J., Boveris A.D., and Boveris A. Vitamin E at high doses improves survival, neurological performance and brain mitochondrial function in aging male mice. Am. J. Physiol., Regul. Integr. Comp. Physiol. 289 (2005) R1392-R1399
31. Panetta J., Smith L.J., and Boneh A. Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases. J. Inherit. Metab. Dis. 27 (2004) 487-498
32. Smeitink J.A.M., Sengers R., Trijbels F., and van den Heuvel L.W. Human NADH:ubiquinone oxidoreductase. J. Bioenerg. Biomembr. 33 (2001) 259-266
33. Nijtmans L.G., Henderson N.S., and Holt I.J. Blue Native electrophoresis to study mitochondrial and other protein complexes. Methods 26 (2002) 327-334
34. Ugalde C., Vogel R., Huijbens R., van den Heuvel L.W., Smeitink J.A.M., and Nijtmans L.G. Human mitochondrial complex I assembles through the combination of evolutionary conserved modules: a framework to interpret complex I deficiencies. Hum. Mol. Genet. 13 (2004) 2461-2472
35. Triepels R.H., Hanson B.J., van den Heuvel L.W., Sundell L., Marusich M.F., Smeitink J.A.M., and Capaldi R.A. Human complex I defects can be resolved by monoclonal antibody analysis into distinct subunit assembly patterns. J. Biol. Chem. 276 (2001) 8892-8897
36. Koopman W.J.H., Verkaart S., Visch H.J., Nijtmans L.G.J., Smeitink J.A.M., and Willems P.H.G.M. Human NADH:ubiquinone oxidoreductase deficiency: radical changes in mitochondrial morphology?. Am. J. Physiol., Cell Physiol. 293 (2007) C22-C29
37. Ahlers P., Garofano A., Kerscher S., and Brandt U. Application of the obligate aerobic yeast Yarrowia lipolytica as a eucaryotic model to analyse Leigh Syndrome mutations in the complex I core subunits PSST and TYKY. Biochim. Biophys. Acta 1459 (2000) 258-265
38. Duarte M., Schulte U., Ushakova A.V., and Videira A. Neurospora strains harboring mitochondrial disease-associated mutations in iron-sulfur subunits of complex I. Genetics 171 (2005) 91-99
39. Brandt U. Energy converting NADH:quinone oxidoreductase (complex I). Annu. Rev. Biochem. 75 (2006) 69-92
40. Adam-Vizi V., and Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol. Sci. 27 (2006) 639-645
41. Tafazoli S., Wright J.S., and O'Brien P.J. Prooxidant and antioxidant activity of vitamin E analogues and troglitazone. Chem. Res. Toxicol. 18 (2005) 1567-1574
42. Rimbach G., Minihane A.M., Majewicz J., Fischer A., Pallauf J., Virgli E., and Weinberg P.D. Regulation of cell signaling by vitamin E. Proc. Nutr. Soc. 61 (2002) 415-425
43. Paradies G., Petrosillo G., Pistolese M., and Ruggiero F.M. Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage. Gene 286 (2002) 135-141
44. Chen Q., and Lesnefsky E.J. Depletion of cardiolipin and cytochrome c during ischemia increases hydrogen peroxide production from the electron transport chain. Free Rad. Biol. Med. 40 (2006) 976-982
45. Pich S., Bach D., Briones P., Liesa M., Camps M., Testar X., Palacin M., and Zorzano A. The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum. Mol. Genet. 14 (2005) 1405-1415
46. Loeffen J.L., Elpeleg O., Smeitink J.A.M., Smeets R.J., Stöckler-Ipsiroglu S., Mandel H., Sengers R., Trijbels F., and van den Heuvel L.P. Mutations in the complex I NDUFS2 gene of patient with cardiomyopathy and encephalomyopathy. Ann. Neurol. 49 (2001) 195-201
47. Schuelke M., Smeitink J.A.M., Mariman E., Loeffen J., Plecko B., Trijbels F., Stockler-Ipsiroglu S., and van den Heuvel L.W. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat. Genet. 21 (1999) 260-261
48. Triepels R.H., van den Heuvel L.P., Loeffen J.L., Buskens C.A., Smeets R.J., Rubio Gozalbo M.E., Mariman E.C., Wijburg F.A., Barth P.G., Trijbels J.M., and Smeitink J.A.M. Leigh syndrome associated with a mutation in the NDUFS7 (PSST) nuclear encoded subunit of complex I. Ann. Neurol. 45 (1999) 787-790